NAM cases with SRP antibodies or statin-exposed HMGCR-positive NAM are generally not associated with malignancy, whereas statin-naïve HMGCR-positive NAM and seronegative NAM may be linked to cancer [6]. This evidence concerns the gene UCN2 and cancer.